Results 71 to 80 of about 2,820 (114)

Long-Term Comparative Outcomes of TNF-α Antagonists vs. Vedolizumab as First-Line Biologic Therapy for Refractory Ulcerative Proctitis: A Propensity-Matched Study. [PDF]

Biomedicines
Shah A, Hussain A, Nawaz A, Chaar A, Kaur A, Aloysius MM, Sapkota B, John S, Goren I.   +8 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Etrasimod Compared With Biologic Therapies for the Treatment of Patients with Moderately-to-Severely Active Ulcerative Colitis in Spain. [PDF]

Pharmacoecon Open
Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E.   +7 more
europepmc   +1 more source

Successful Surgical Treatment of Pediatric Intestinal Behçet's Disease with Ileocecal Ulcer Refractory to Medical Therapy: A Case Report. [PDF]

Surg Case Rep
Nagashima K, Mizuno Y, Miyaoka F, Irabu H, Innami Y, Kamata Y, Ito Y, Okamoto K, Shimizu M, Tanaka Y, Ohashi K, Aruga T.   +11 more
europepmc   +1 more source

Biosimilars in Adult and Pediatric Noninfectious Uveitis. [PDF]

Clin Ophthalmol
Ploeger CG, Carvalho Soares Valentim C, Guner ME, Kabaalioglu Guner M.   +3 more
europepmc   +1 more source

The Relative Effects of Monotherapies for Psoriatic Nails: A Network Meta-Analysis Study. [PDF]

J Cosmet Dermatol
Gupta AK, Bamimore MA, Wang T, Talukder M.   +3 more
europepmc   +1 more source

Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practice. [PDF]

Pediatr Rheumatol Online J
Lamers HC, Van Nieuwenhove E, Vastert SJ, Jansen MHA, van Royen-Kerkhof A, Swart JF, de Roock S.   +6 more
europepmc   +1 more source

Real-Life Use of Subcutaneous Biologicals and JAK Inhibitors in IBD Maintenance Therapy: Treatment Continuation, Switching Patterns, and Concomitant Medications. [PDF]

Clin Exp Gastroenterol
Koivusalo M, Jokelainen J, Huhtinen A, Kovac B, Silvola S, Torvinen S, Ylisaukko-Oja T, Arkkila P.   +7 more
europepmc   +1 more source

Pharmacokinetic Similarity of Biosimiliar AVT05 Versus Reference Product Golimumab in Healthy Adults: A Double-Blind, Three-Arm, Parallel-Group Study. [PDF]

BioDrugs
Wynne C, Lorch U, Krantz E, Katial R, Ashdown T, Luque M, Sattar A, Rai M, Vashishta L, Petrovic K, Ruffieux R, Leutz S, Berti F.   +12 more
europepmc   +1 more source

Effect of Biologic Therapies in Treating Moderate-to-Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Thadiboina O, Shah SSA, Ray R, Hack SA, Munir M, Shah Q, Bhullar A, Shah SZH, Ali MAM, Nureen U, Afzal S, Izzat I.   +11 more
europepmc   +1 more source

Development of New Molecularly Targeted Agents in Inflammatory Bowel Disease. [PDF]

Intern Med
Nakase H.
europepmc   +1 more source